Clinical Trials
7 trialsNCT07596524 2026-05-19
Analysis of Different Second Line Treatment in Advanced NSCLC Patients Progressing After 1st Line Immune Checkpoint Inhibitor Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not yet recruiting
NCT07472478 2026-03-16
GIVEN
Guangdong Provincial People's Hospital
Phase 2 Not yet recruiting
NCT07239544 2025-11-20
Generation of Reactive T Cells Based on Tumor Whole Cell Antigen Nanovaccines
The First Affiliated Hospital of Soochow University
Active not recruiting
NCT06448455 2024-06-10
Observation on the Frailty Status of Lung Cancer Patients
Peking University Third Hospital
Recruiting
NCT05857800 2023-06-08
NAT-LungMate
Shanghai Pulmonary Hospital, Shanghai, China
Recruiting
NCT05082636 2021-10-25
The Role of Programmed Death Ligand -1 (Pdl-1) in Lung Cancer
Assiut University
Completed
NCT02852629 2017-09-18
CBP-Aggrav
University Hospital, Grenoble
Completed